期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Minimally Invasive Neuronavigator-guided Microsurgery and Photodynamic Therapy for Gliomas
1
作者 王业忠 雷霆 王智 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第3期395-398,共4页
In order to evaluate the effectiveness ofneuronavigator-guided microsurgery and keyhole technique for the resection of gliomas, a total of 60 patients with gliomas were exactly located by using neuronavigator during m... In order to evaluate the effectiveness ofneuronavigator-guided microsurgery and keyhole technique for the resection of gliomas, a total of 60 patients with gliomas were exactly located by using neuronavigator during microsurgery. Forty deep-seated gliomas were resected through a keyhole operative approach. Thirty out of the 60 cases were subjected to photodynamic therapy (PDT) after tumor resection. The therapeutic effectiveness of all the cases was recorded and analyzed. The resuits showed that glioma was totally resected in 52 cases (86.7%), subtotally in 5 (8.3%), and most partially in 3 (5%). Neurological deficits occurred postoperatively in 4 cases. One patient died of multiple system organ failure 4 days after operation. It was concluded that the application of minimally invasive technique could dramatically decrease surgical complications following resection of glioma, and its combination with PDT could obviously improve the quality of life of patients and prolong the survival time. 展开更多
关键词 NEURONAVIGATION keyhole surgery GLIOMA photodynamic therapy
下载PDF
HEMOGLOBIN CHONGQING (α2(NA 2) LEU→ARG) AND HEMOGLOBIN HARBIN (α16(A14)LYS→MET)——TWO NEW UNSTABLE HEMO GLOBIN VARIANTS FOUND IN CHINA
2
作者 焦春堂 陈崇远 +10 位作者 唐治贵 鲍希桓 曾立志 段玉芹 张贵寅 曾溢滔 黄淑帧 仇效坤 丛建平 李敏跃 金群策 《Chinese Science Bulletin》 SCIE EI CAS 1985年第11期1562-,共1页
During the survey of hemoglobinopathies, a slow-moving and unstable hemoglobin variant was found in four members of a Chinese family in Chongqing of Sichuan Province, and another fast-moving and slight unstable hemogl... During the survey of hemoglobinopathies, a slow-moving and unstable hemoglobin variant was found in four members of a Chinese family in Chongqing of Sichuan Province, and another fast-moving and slight unstable hemoglobin var- 展开更多
关键词 HEMOGLOBIN UNSTABLE Chongqing A14)LYS ARG LEU MET NA 2 FOUND slight
原文传递
Current status of anticoagulant treatments and improvements for hemodialysis patients in northern Chinese cities: a five-year comparative study 被引量:3
3
作者 Huang Qi Sun Xuefeng +8 位作者 Lin Hongli Zhang Zhimin Hao Lirong Yao Li Li Jijun Zhao Delong Wang Yong Zhu Hanyu Chen Xiangmei 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第16期2881-2887,共7页
Background Anticoagulation treatments are an important aspect of hemodialysis; however,few reports have addressed these treatments.This investigation intends to increase the understanding of the current status and imp... Background Anticoagulation treatments are an important aspect of hemodialysis; however,few reports have addressed these treatments.This investigation intends to increase the understanding of the current status and improvements of hemodialysis-related anticoagulation treatments in China.Methods In this study,an epidemiological investigation was conducted that examined 842 patients in 2007 and 1 175patients in 2012 who underwent hemodialysis anticoagulation treatments in seven blood purification centers in northern Chinese cities.Results Heparin was the most commonly used anticoagulant,although the percentage of use of low-molecular-weight heparin (LMWH) increased from 26.5% in 2007 to 42.1% in 2012.In 2007,there were no significant differences in anticoagulant selection among either patients with various primary diseases or patients with hemorrhage,thrombosis,thrombocytopenia,or a low hemoglobin level.However,compared with patients with other diseases,significantly lower doses of LMWH were administered to patients with hypertension (55.5 U/kg vs.67.3 U/kg,P 〈0.05) or diabetes (58.5 U/kg vs.67.3 U/kg,P 〈0.05),and patients with hemorrhage received lower doses of heparin than the other patients (61.6 U/kg vs.71.8 U/kg,P 〈0.01).In 2012,patients with diabetic nephropathy (51.5% vs.36.5%,P 〈0.01),hemorrhage (43.4% vs.31.7%,P 〈0.01),or a hemoglobin level below 90 g/L (57.2% vs.37.1%,P 〈0.01) experienced significantly higher doses of LMWH administration; patients with hemorrhage received significantly reduced LMWH dosages (50.4 U/kg vs.57.8 U/kg,P 〈0.05),and patients with thrombosis received significantly higher doses of heparin (73.8 U/kg vs.62.1 U/kg,P 〈0.01) or LMWH (57.8 U/kg vs.52.6 U/kg,P 〈0.05).Antiplatelet drugs were administered to 20.4% of the examined patients in 2007 and 20.7% in 2012.In 2012,patients with hypertension (25.9% vs.18.5%,P 〈0.01) and thrombosis (36.6% vs.16.1%,P 〈0.01) had a higher rate of using antiplatelet drugs than patients with other primary diseases and complications.Patients receiving antiplatelet drugs also received higher doses of heparin than patients without using antiplatelet drugs (74.4 U/kg vs.65.9 U/kg,P 〈0.01).However,the use of the drugs was not correlated with thrombocytopenia.The rate at which coagulation indices were determined increased from 45.7% in 2007 to 64% in 2012.Conclusion These findings suggested that hemodialysisrelated anticoagulation treatments in China have gradually become more standardized and individualized. 展开更多
关键词 HEMODIALYSIS HEPARIN low-molecular-weight heparin ANTICOAGULANT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部